Kyle D. Brizendine

832 total citations
29 papers, 560 citations indexed

About

Kyle D. Brizendine is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Kyle D. Brizendine has authored 29 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Kyle D. Brizendine's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (12 papers) and Pneumonia and Respiratory Infections (5 papers). Kyle D. Brizendine is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (12 papers) and Pneumonia and Respiratory Infections (5 papers). Kyle D. Brizendine collaborates with scholars based in United States. Kyle D. Brizendine's co-authors include Peter G. Pappas, John W. Baddley, Vasilios Athans, Sandra S. Richter, Eric Cober, Elizabeth Neuner, David van Duin, Amy J. Mathers, Mariana Castanheira and Ryan Miller and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Kyle D. Brizendine

27 papers receiving 556 citations

Peers

Kyle D. Brizendine

EPIDE

PHARM

AMB

Maria Daniela Bergamasco Brazil

Rossana Rosa United States

Asia Obman United States

Pedro Torres‐González Mexico

Juan José Castón Spain

Caterina Campoli Italy

M.-E. Bougnoux France

Maite Ruíz Spain

Ferdinando Dodi Italy

Jill A. Nord United States

Maria Daniela Bergamasco Brazil

Kyle D. Brizendine

295 ×0.7

EPIDE

258 ×0.8

131 ×1.2

76 ×0.9

PHARM

38 ×0.8

AMB

Citations per year, relative to Kyle D. Brizendine Kyle D. Brizendine (= 1×) peers Maria Daniela Bergamasco

Countries citing papers authored by Kyle D. Brizendine

Since Specialization

Citations

This map shows the geographic impact of Kyle D. Brizendine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle D. Brizendine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle D. Brizendine more than expected).

Fields of papers citing papers by Kyle D. Brizendine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle D. Brizendine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle D. Brizendine. The network helps show where Kyle D. Brizendine may publish in the future.

Co-authorship network of co-authors of Kyle D. Brizendine

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle D. Brizendine. A scholar is included among the top collaborators of Kyle D. Brizendine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle D. Brizendine. Kyle D. Brizendine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chute, Deborah J., et al.. (2025). P-1036. Invasive fungal Rhinosinusitis in solid organ and hematopoietic stem cell transplant recipients at a tertiary care center in the United States. Open Forum Infectious Diseases. 12(Supplement_1).

Hsich, Eileen, et al.. (2025). Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era. Clinical Transplantation. 39(8). e70248–e70248. 1 indexed citations

Athans, Vasilios, et al.. (2020). Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study. International Journal of Antimicrobial Agents. 55(3). 105886–105886. 9 indexed citations

Brizendine, Kyle D., et al.. (2019). Retrospective study evaluating the performance of risk factors for invasive mold infections in liver transplantation. Transplant Infectious Disease. 22(1). e13223–e13223. 8 indexed citations

Wang, Nan, et al.. (2018). A pharmacist‐driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients. Transplant Infectious Disease. 20(6). e12991–e12991. 21 indexed citations

John, Teny M., Abhishek Deshpande, Sarah Haessler, et al.. (2018). 1457. Escherichia coli Community Acquired Pneumonia. Open Forum Infectious Diseases. 5(suppl_1). S451–S451. 1 indexed citations

Athans, Vasilios, Elizabeth Neuner, Sandra S. Richter, et al.. (2018). Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient. Antimicrobial Agents and Chemotherapy. 63(1). 68 indexed citations

Brizendine, Kyle D., et al.. (2017). Real-World Use – Isavuconazole at a Large Academic Medical Center. Open Forum Infectious Diseases. 4(suppl_1). S82–S82. 3 indexed citations

Deshpande, Abhishek, Sarah Haessler, Kyle D. Brizendine, et al.. (2016). Epidemiology of Healthcare-Associated Pneumonia (HCAP) as Assessed by Blood Cultures Versus Respiratory Cultures. Open Forum Infectious Diseases. 3(suppl_1).

10.

Sacha, Gretchen L., Elizabeth Neuner, Vasilios Athans, et al.. (2016). Clinical Experience With Ceftolozane/Tazobactam at a Large Academic Medical Center. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

11.

John, Teny M. & Kyle D. Brizendine. (2016). Combination Antifungal Therapy for Invasive Aspergillosis Among Patients with Hematopoietic Cell Transplantation and Positive Galactomannan. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

12.

Kovacs, Christopher, Christine Koval, David van Duin, et al.. (2014). Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. World Journal of Transplantation. 4(2). 43–43. 21 indexed citations

13.

Brizendine, Kyle D.. (2014). Ebola virus: Questions, answers, and more questions. Cleveland Clinic Journal of Medicine. 81(12). 729–735. 4 indexed citations

14.

Baddley, John W., David R. Andes, Kieren A. Marr, et al.. (2013). Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Medical Mycology. 51(2). 128–135. 24 indexed citations

15.

Brizendine, Kyle D., John W. Baddley, & Peter G. Pappas. (2013). Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status. PLoS ONE. 8(3). e60431–e60431. 185 indexed citations

16.

Brizendine, Kyle D., et al.. (2012). Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis. Transplant Infectious Disease. 14(4). E13–8. 12 indexed citations

17.

Brizendine, Kyle D., et al.. (2011). Antifungal prophylaxis in solid organ transplant recipients. Expert Review of Anti-infective Therapy. 9(5). 571–581. 15 indexed citations

18.

Brizendine, Kyle D., John W. Baddley, & Peter G. Pappas. (2011). Pulmonary Cryptococcosis. Seminars in Respiratory and Critical Care Medicine. 32(6). 727–734. 50 indexed citations

19.

Brizendine, Kyle D., J. Michael Wells, Scott A. Flanders, Sanjay Saint, & Robert M. Centor. (2010). In Search of . . .. New England Journal of Medicine. 363(23). 2249–2254. 4 indexed citations

20.

Brizendine, Kyle D. & Peter G. Pappas. (2010). Cryptococcal Meningitis: Current Approaches to Management in Patients With and Without AIDS. Current Infectious Disease Reports. 12(4). 299–305. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact